Skip to main content
Equibles

MARTINGALE ASSET MANAGEMENT L P

Position in FTRE — Fortrea Holdings Inc.

CIK 936944 BOSTON, MA
Back to FTRE Full portfolio

Position in FTRE

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,957,778
+$1,233,870 QoQ
Shares Held
112,516
+46.4% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#85
of 334 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority Sole 34% Shared 0% None 66%

Common Shares in FTRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARTINGALE ASSET MANAGEMENT L P holds $144,833,314 across 62 Biotechnology names. FTRE ranks #20 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 42,729 $21,224,776
2 INCY
Incyte Corp
 168,818 $19,137,208
3 JAZZ
Jazz Pharmaceuticals plc
 59,492 $14,335,787
4 REGN
Regeneron Pharmaceuticals, Inc.
 18,953 $11,817,953
5 LGND
Ligand Pharmaceuticals Inc
 17,562 $5,551,172
6 ACAD
Acadia Pharmaceuticals Inc
 167,893 $4,247,692
7 ALNY
Alnylam Pharmaceuticals, Inc.
 13,634 $4,104,243
8 INVA
Innoviva, Inc.
 165,115 $3,749,761

All Filings in FTRE

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,957,778 112,516
2026-03-31 $723,908 76,848
2025-12-31 $1,127,753 65,377
2025-09-30 $691,105 82,079
2025-06-30 $142,020 28,749